Suggestions
Andrew Hedin
Partner at Bessemer Venture Partners
Andrew Hedin is a partner at Bessemer Venture Partners, a global venture capital firm with a strong focus on investing in early-stage, high-growth companies across various sectors, including healthcare. He is based in the Cambridge, Massachusetts office and specializes in investments across the healthcare ecosystem, particularly in high-growth biotech and healthcare companies.12
Background and Education
- Education: Andrew holds a Bachelor of Arts in Biological Basis of Behavior (Neuroscience) and Health Care Management from the University of Pennsylvania. He also earned an MBA from The Wharton School, where he majored in Health Care Management and Finance.13
- Family Background: He grew up in Western New York with a family that emphasized faith, football, and family. His mother is a physical therapist, and his father is a Lutheran pastor, which instilled in him a desire to make a positive impact.2
Professional Experience
- Bessemer Venture Partners: Andrew has been a partner since July 2015. He serves on the boards of companies like Kymera Therapeutics, TScan Therapeutics, and Nido Biosciences, among others.1
- Previous Roles: Before joining Bessemer, Andrew worked at F-Prime Capital Partners (formerly Fidelity Biosciences) from 2010 to 2013, focusing on investments in biotech, medtech, and health IT companies. He also worked at Leerink Partners LLC from 2007 to 2010 as an analyst in their boutique investment banking and consulting firm focused on life sciences.1
Research and Early Career
- Neuroscience Research Assistant: Andrew conducted research in the University of Pennsylvania's neuroscience lab under Tracy Bale, focusing on stress sensitivity related to neurodevelopmental and neuropsychiatric diseases.1
- Penn Resiliency Project: He was involved as a research supervisor for this project, which aimed to teach cognitive-behavioral skills to students.1
Andrew's career reflects a strong commitment to healthcare and venture capital, with a focus on making impactful investments in innovative healthcare companies.
Highlights
JPM 2024 is on! After running around SF all day, I'm finally sitting down in a hotel lobby to grab some wifi to share our Bessemer Venture Partners predictions for 2024
Let us know what you think and whether we missed any of your top predictions!
We're especially grateful this year to leverage the real experts (our portfolio founders) for guidance on what they're seeing "on the ground". Thank you to Seismic Therapeutic, Mural Health, Plenful, CopilotIQ, Oshi Health, House Rx, Rupa Health, Headspace, Abridge, FOLX Health, USHP, and many others for sharing their perspectives going into the new year.
Steve Kraus, Sofia Guerra, Morgan Cheatham
Check out the link for more information: https://lnkd.in/g7Biz5RG
